Developer docs
API playgroundTry for free, no card

Search company profiles

Zcube

Full company profile

uuid000awq7

Namestring
Zcube
Legal namestring
Zcube S.r.l
Websiteurl
zambon.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Zcube S.r.l is the corporate research venture and innovation arm of the Italian pharmaceutical group Zambon Company S.p.A., focused on identifying, accelerating, and investing in early-stage digital health companies whose technologies complement traditional pharmaceutical therapies. The company operates two principal mechanisms: the Open Accelerator program, an international acceleration cohort for Life Sciences and femtech startups (the 2024 edition selected five startups with a women's health focus), and direct equity investments in portfolio companies, exemplified by the C$2 million lead investment in Canadian startup Hyivy Health in September 2024. Zcube is headquartered at Via Lillo del Duca, 10, 20091 Bresso, Italy, and is registered as a wholly-owned subsidiary of Zambon Company S.p.A. with declared share capital of EUR 320,000.

The business model is that of a strategic corporate venture vehicle: Zcube does not sell a disclosed product or service but captures returns through equity participation in accelerator cohorts and direct investments, pairing capital with access to Zambon's pharmaceutical regulatory expertise, clinical networks, and distribution reach across the parent group's 87-country footprint. Its core technology positioning is broadly characterized as "digital health technologies used alongside traditional therapies," with no proprietary models, patents, or technology stack disclosed in the input material. Revenue for Zcube specifically is not publicly disclosed and appears not to be generated through commercial product sales; the EUR 899 million revenue figure cited belongs to the Zambon Group parent, which employs approximately 2,768 people globally.

Leadership oversight is provided through the Zambon Group's family governance structure, with Elena Zambon serving as President of Zcube. The company's customer or counterparties are limited in number and concentrated among a small annual accelerator cohort and a handful of direct portfolio companies, reflecting the structural concentration inherent to venture investing rather than a transactional SaaS or licensing business.

Short descriptiontext

Zcube, the corporate research venture arm of Italian pharmaceutical group Zambon Company S.p.A., scouts, accelerates, and invests in early-stage digital health startups. It operates the Open Accelerator program for Life Sciences companies and makes direct equity investments in digital therapeutics complementing traditional pharmaceutical products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersBresso, Italy
HQ citystring
Bresso
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health innovation, startup acceleration program, corporate venture capital, life sciences investment, digital therapeutics research
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Corporate Venture & Digital Health Innovation
Social media profiles1 record
Cost components3 values
Others, Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Zcube is the Zambon Group's research venture that identifies, invests in, and develops digital health solutions to be used alongside traditional pharmaceutical therapies. It operates the Open Accelerator program for Life Sciences startups and makes direct venture investments in early-stage digital health companies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Zcube is Zambon's dedicated research venture focused on digital health innovation. It operates as an investment and acceleration vehicle that scouts, acquires, licenses, and develops new digital solutions to complement traditional pharmaceutical therapies. Zcube runs the Open Accelerator program and makes strategic investments in digital health startups.

Product and service2 records
1Zcube (Zambon Research Venture)
CategoryResearch Venture
Description

Zambon's research venture focused on identifying and developing modern solutions to improve patients' lives, based on the use of digital technologies to be used alongside traditional therapies. It scouts, acquires, licenses, and develops new digital solutions and makes strategic investments in digital health startups.

2Open Accelerator
CategoryStartup Acceleration Program
Description

An international acceleration program for startups in the Life Sciences sector, providing mentorship, resources, and potential investment to early-stage companies developing innovative health solutions. In 2024 the program focused on women's health and Femtech, with 5 startups selected to participate.

Partnership1 partner
1Open Accelerator Program Participants
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Zcube runs the Open Accelerator program, an international acceleration program for startups in the Life Sciences sector. In 2024, the program was focused on women's health and Femtech, with 5 startups selected to participate. The program provides mentorship, resources, and potential investment to early-stage companies developing innovative health solutions.

zambon.com
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Startupbootcamp Digital Health
TypeEmerging player
Description

European-based accelerator running cohort programs for digital health startups with mentorship from corporate partners. Comparable to Zcube's Open Accelerator in cohort structure and European footprint.

2EIT Health
TypeBroad incumbent
Description

European public-private partnership network that accelerates healthcare innovation through programs, funding, and ecosystem building. Comparable to Zcube's mission of fostering digital health innovation in Europe, though broader in scope and mandate.

3Plug and Play Health
TypeEmerging player
Description

A global startup accelerator with a dedicated Health vertical that runs cohort programs for digital health, biotech, and insurtech startups. Comparable to Zcube's accelerator model though not pharma-affiliated.

4Cedars-Sinai Accelerator
TypeEmerging player
Description

A US-based health system accelerator for digital health and healthtech startups, providing mentorship and clinical validation. Comparable to Zcube's Open Accelerator as a structured cohort-based accelerator focused on health innovation.

5IndieBio
TypeEmerging player
Description

A biotech and healthtech accelerator providing seed funding and mentorship to early-stage life sciences startups. Comparable to Zcube as an early-stage life sciences accelerator, though IndieBio is more biotech-focused and not pharma-affiliated.

6Sanofi Partner Healthcare Innovation
TypeDirect peer
Description

Sanofi's digital health partnership and venture efforts aimed at connecting the pharma giant with healthtech innovators. Comparable to Zcube as a pharma corporate venture arm running startup engagement programs.

7Novartis Biome
TypeDirect peer
Description

Novartis's digital health innovation hub that scouts, partners with, and invests in healthtech startups. Highly comparable to Zcube as a pharma-backed digital health venture and accelerator operating at the intersection of technology and therapeutics.

8Pfizer Healthcare Hub
TypeDirect peer
Description

Pfizer's accelerator and partnership program for digital health and biotech startups. Comparable as a large pharma corporate venture offering structured acceleration, mentorship, and potential commercial pathways to portfolio companies.

9Bayer G4A (Co.Lab)
TypeDirect peer
Description

Bayer's global digital health startup accelerator and partnership program. Directly comparable as a major pharma corporate venture platform focused on digital health innovation, running cohort-based acceleration and direct investments.

10Roche Innovation / pRED Digital
TypeDirect peer
Description

Roche's digital health and diagnostics innovation initiatives, including venture and partnership programs. Directly comparable as a major pharma corporate venture platform engaging with digital health startups alongside traditional pharma.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment7 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Zcube

Corporate Venture & Digital Health Innovationzambon.com

Zcube, the corporate research venture arm of Italian pharmaceutical group Zambon Company S.p.A., scouts, accelerates, and invests in early-stage digital health startups. It operates the Open Accelerator program for Life Sciences companies and makes direct equity investments in digital therapeutics complementing traditional pharmaceutical products.

What Zcube does

Zcube S.r.l is the corporate research venture and innovation arm of the Italian pharmaceutical group Zambon Company S.p.A., focused on identifying, accelerating, and investing in early-stage digital health companies whose technologies complement traditional pharmaceutical therapies. The company operates two principal mechanisms: the Open Accelerator program, an international acceleration cohort for Life Sciences and femtech startups (the 2024 edition selected five startups with a women's health focus), and direct equity investments in portfolio companies, exemplified by the C$2 million lead investment in Canadian startup Hyivy Health in September 2024. Zcube is headquartered at Via Lillo del Duca, 10, 20091 Bresso, Italy, and is registered as a wholly-owned subsidiary of Zambon Company S.p.A. with declared share capital of EUR 320,000.

The business model is that of a strategic corporate venture vehicle: Zcube does not sell a disclosed product or service but captures returns through equity participation in accelerator cohorts and direct investments, pairing capital with access to Zambon's pharmaceutical regulatory expertise, clinical networks, and distribution reach across the parent group's 87-country footprint. Its core technology positioning is broadly characterized as "digital health technologies used alongside traditional therapies," with no proprietary models, patents, or technology stack disclosed in the input material. Revenue for Zcube specifically is not publicly disclosed and appears not to be generated through commercial product sales; the EUR 899 million revenue figure cited belongs to the Zambon Group parent, which employs approximately 2,768 people globally.

Leadership oversight is provided through the Zambon Group's family governance structure, with Elena Zambon serving as President of Zcube. The company's customer or counterparties are limited in number and concentrated among a small annual accelerator cohort and a handful of direct portfolio companies, reflecting the structural concentration inherent to venture investing rather than a transactional SaaS or licensing business.

Zcube firmographics

Firmographics
Name
Zcube
Legal name
Zcube S.r.l
Website
https://zambon.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Zcube, the corporate research venture arm of Italian pharmaceutical group Zambon Company S.p.A., scouts, accelerates, and invests in early-stage digital health startups. It operates the Open Accelerator program for Life Sciences companies and makes direct equity investments in digital therapeutics complementing traditional pharmaceutical products.
Ownership category
akta.pro rank

Where Zcube is headquartered

Location

Headquarters

HQ city
Bresso
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

Zcube business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Others, Personnel, Operations

Zcube product offering

Product offering

Core offering

Zcube is the Zambon Group's research venture that identifies, invests in, and develops digital health solutions to be used alongside traditional pharmaceutical therapies. It operates the Open Accelerator program for Life Sciences startups and makes direct venture investments in early-stage digital health companies.

Product overview

Zcube is Zambon's dedicated research venture focused on digital health innovation. It operates as an investment and acceleration vehicle that scouts, acquires, licenses, and develops new digital solutions to complement traditional pharmaceutical therapies. Zcube runs the Open Accelerator program and makes strategic investments in digital health startups.

Differentiator

Problem solved

Functional benefit

Products and services

  • Zcube (Zambon Research Venture) Zambon's research venture focused on identifying and developing modern solutions to improve patients' lives, based on the use of digital technologies to be used alongside traditional therapies. It scouts, acquires, licenses, and develops new digital solutions and makes strategic investments in digital health startups.
  • Open Accelerator An international acceleration program for startups in the Life Sciences sector, providing mentorship, resources, and potential investment to early-stage companies developing innovative health solutions. In 2024 the program focused on women's health and Femtech, with 5 startups selected to participate.

Companies that use Zcube

Customer profile

Segments1 record

Ideal customer profiles1 record

Zcube technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Zcube partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Open Accelerator Program ParticipantscoreStrategic or Co-development PartnerZcube runs the Open Accelerator program, an international acceleration program for startups in the Life Sciences sector. In 2024, the program was focused on women's health and Femtech, with 5 startups selected to participate. The program provides mentorship, resources, and potential investment to early-stage companies developing innovative health solutions.

Recent moves3 records

Expansion highlights4 records

Zcube competitors and assessment

Company assessment

Emerging players

  • Startupbootcamp Digital Health: European-based accelerator running cohort programs for digital health startups with mentorship from corporate partners. Comparable to Zcube's Open Accelerator in cohort structure and European footprint.
  • Plug and Play Health: A global startup accelerator with a dedicated Health vertical that runs cohort programs for digital health, biotech, and insurtech startups. Comparable to Zcube's accelerator model though not pharma-affiliated.
  • Cedars-Sinai Accelerator: A US-based health system accelerator for digital health and healthtech startups, providing mentorship and clinical validation. Comparable to Zcube's Open Accelerator as a structured cohort-based accelerator focused on health innovation.
  • IndieBio: A biotech and healthtech accelerator providing seed funding and mentorship to early-stage life sciences startups. Comparable to Zcube as an early-stage life sciences accelerator, though IndieBio is more biotech-focused and not pharma-affiliated.

Broad incumbents

  • EIT Health: European public-private partnership network that accelerates healthcare innovation through programs, funding, and ecosystem building. Comparable to Zcube's mission of fostering digital health innovation in Europe, though broader in scope and mandate.

Direct peers

  • Sanofi Partner Healthcare Innovation: Sanofi's digital health partnership and venture efforts aimed at connecting the pharma giant with healthtech innovators. Comparable to Zcube as a pharma corporate venture arm running startup engagement programs.
  • Novartis Biome: Novartis's digital health innovation hub that scouts, partners with, and invests in healthtech startups. Highly comparable to Zcube as a pharma-backed digital health venture and accelerator operating at the intersection of technology and therapeutics.
  • Pfizer Healthcare Hub: Pfizer's accelerator and partnership program for digital health and biotech startups. Comparable as a large pharma corporate venture offering structured acceleration, mentorship, and potential commercial pathways to portfolio companies.
  • Bayer G4A (Co.Lab): Bayer's global digital health startup accelerator and partnership program. Directly comparable as a major pharma corporate venture platform focused on digital health innovation, running cohort-based acceleration and direct investments.
  • Roche Innovation / pRED Digital: Roche's digital health and diagnostics innovation initiatives, including venture and partnership programs. Directly comparable as a major pharma corporate venture platform engaging with digital health startups alongside traditional pharma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Zcube social profiles

Digital presence

Zcube financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Zcube leadership team

Management profile

Number of profiles

Profiles1 record

Zcube funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Zcube M&A and investment

M&A and investment

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zcube

What does Zcube do?

Zcube is the Zambon Group's research venture that identifies, invests in, and develops digital health solutions to be used alongside traditional pharmaceutical therapies. It operates the Open Accelerator program for Life Sciences startups and makes direct venture investments in early-stage digital health companies.

Is Zcube a public or private company?

Zcube is a private company. It is classified as corporate owned and is currently operating.

When was Zcube founded?

Zcube was founded in 2003. It employs 1,001 to 5,000 people.

Where is Zcube based?

Zcube is headquartered in Bresso, Italy, in the Europe region.

Who are Zcube's main competitors?

Emerging players on record are Startupbootcamp Digital Health, Plug and Play Health, Cedars-Sinai Accelerator and IndieBio. EIT Health is listed as a broad incumbent. Direct peers are Sanofi Partner Healthcare Innovation, Novartis Biome, Pfizer Healthcare Hub, Bayer G4A (Co.Lab) and Roche Innovation / pRED Digital.

Does Zcube have an API?

No public API is recorded for Zcube.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Private Capital JournalHyivy Health secures $2M seed financingHyivy Health Inc. has secured $2 million in seed funding led by Zcube – Zambon Research Venture to advance its Hyivy Pelvic Health Rehabilitation System. The startup intends to use this capital to expand clinical trials and prepare for an alpha launch in the U.S., specifically targeting clinics in California. This development follows recent Health Canada approvals and aims to replace current standards of care for chronic pelvic pain.ZambonZcube - Zambon Research Venture leads a C$2 million investment round in canadian startup Hyivy HealthZcube - Zambon Research Venture led a C$2 million investment round in Canadian startup Hyivy Health, which focuses on pelvic health rehabilitation. The investment aims to enhance innovations in women's health, following Hyivy Health's participation in Zcube's Open Accelerator program and recent clinical trials approved by Health Canada. The startup's technology addresses chronic pelvic pain and introduces a novel benchmark in patient healthcare.PR NewswireZcube lanza la tercera edición del programa Open AcceleratorZcube, the research venture of Zambon Pharmaceutical Group, launched the third edition of its international Open Accelerator program focused on central nervous system, respiratory system, and rare diseases. Selected participants will receive up to 100,000 euros in seed capital investment, free access to labs and office space at the OpenZone campus near Milan, and the opportunity to develop projects in collaboration with Zambon. The program is run in partnership with Officine Innovazione (Deloitte) and supported by collaborators including Italian Angels for Biotech, Innogest, Premio Marzotto, Unicredit StartLab, and Bird & Bird.PR NewswireZcube startet die dritte Auflage von Open Accelerator für Start-Ups mit Ausrichtung auf die Bereiche zentrales Nervensystem und AtemwegeZcube, the research arm of Zambon Pharmaceutical Group, has launched the third edition of its international Open Accelerator program, focused on the central nervous system (CNS) and respiratory areas, including rare diseases. The program targets researchers, scientists, and emerging entrepreneurs, offering seed funding of up to €100,000 and free access to laboratories and office space at the OpenZone life sciences campus near Milan. Applications are accepted until June 30, 2018, and the program is conducted in collaboration with Officine Innovazione (Deloitte) and supported by partners including Italian Angels for Biotech, Innogest, Unicredit StartLab, and Bird & Bird.PR NewswireZcube lance la troisième édition d'Open Accelerator pour Start-Ups dans le domaine du système nerveux central et de l'appareil respiratoireZcube, the research division of Zambon Pharmaceutical Group, launched the third edition of its Open Accelerator program focused on central nervous system and respiratory diseases, including rare diseases, targeting researchers, scientists, and entrepreneurs. Selected participants will receive up to €100,000 in initial investment and access to free laboratory and office space at Zambon's OpenZone life sciences campus. The call for projects runs until June 30, 2018, with the program delivered in partnership with Deloitte's Officine Innovazione and supported by partners including Italian Angels for Biotech, Innogest, and Unicredit StartLab.FinSMEsZCube Launches Second Edition of Open AcceleratorZCube launched the second edition of Open Accelerator, a Milan-based program for life science startups. The 12-step program offers training and mentoring, with up to €100k seed investment per project for selected ideas. The call for ideas is open until 16 July 2017.